Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell ResponseMariëtte I.E. van Poelgeest, Sjoerd H. van der Burg, Hans W. Nijman et al.|Clinical Cancer Research|2016Cited by 166
<sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic TreatmentSjoukje F. Oosting, Elisabeth G.E. de Vries, Adrienne H. Brouwers et al.|Journal of Nuclear Medicine|2014Cited by 114
VEGF-SPECT with 111In-bevacizumab in stage III/IV melanoma patientsWouter B. Nagengast, Geke A.P. Hospers, Marjolijn N. Lub–de Hooge et al.|European Journal of Cancer|2011Cited by 55
Characteristics of Lynch syndrome associated ovarian cancerJorien M. Woolderink, Marian J.E. Mourits, Geertruida H. de Bock et al.|Gynecologic Oncology|2018Cited by 29
Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancerNinke Leffers, Hans W. Nijman, Marloes J.M. Gooden et al.|Gynecologic Oncology|2009Cited by 22